Anne Frederick

Anne Frederick has a wealth of experience in the pharmaceutical industry, starting in 2004 as a Director at Pfizer. Anne then worked at Innovive as a Senior Director before moving to Novartis Oncology as an Executive Director of Drug Regulatory Affairs. Anne further advanced their career at LOXO Oncology, Inc. as a VP of Regulatory Affairs and then at Celgene as an Executive Director of Regulatory Affairs. Anne continued to excel in their field at TG Therapeutics, Inc., where they served as VP of Regulatory Affairs. Following this, Anne held the position of VP of Global Regulatory Strategy at Alkermes. Anne'smost recent role was at Zentalis Pharmaceuticals as the SVP of Clinical Regulatory. Throughout their career, Anne has gained extensive experience and knowledge in various regulatory roles within the pharmaceutical industry.

Anne Frederick earned a Bachelor's degree in Chemistry from Kalamazoo College. Anne also holds a Doctor of Philosophy (Ph.D.) degree in Chemistry from Yale University.